- Exchange: London
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
GW Pharmaceuticals PLC
Add to PortfolioGWP:LN
79.0000 GBp 0.5000 0.64%As of 11:35:28 ET on 05/25/2012.
Snapshot for GW Pharmaceuticals PLC (GWP)
| Open: | 80.0000 | Day's Range: | 78.0000 - 80.0000 | Volume: | 26,884 | Bid: | 78.0000 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 78.5000 | 52wk Range: | 73.5000 - 133.0000 | 1-Yr Rtn: | -36.80% | Ask: | 80.0000 |
Key Statistics for GWP
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (09/2012) | 32.9167 |
| Earnings Per Share (GBP) (ttm) | -0.0280 |
| Est. EPS (GBP) (09/2012) | 0.0240 |
| Est. PEG Ratio | - |
| Market Cap (M GBP) | 105.11 |
| Shares Outstanding (M) | 133.06 |
| Enterprise Value (M GBP) (ttm) | 78.90 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 6.9836 |
| Price/Sale (ttm) | 4.3447 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 11/22/2012 |
More GWP Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for GWP
- Operating
- Investing
- Financing (M/GBP)
Company Profile & Key Executives for GWP
GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.
| Geoffrey William GuyChairman/Founder | James J NobleDeputy Chairman |
| David KirkFinance Director | Justin David GoverManaging Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page